Back to All Events

IP Collective - Life Sciences North America

Navigating Changes in the Life Sciences Landscape to Leverage the Value of IP

Over the past two decades, innovation within the life sciences sector has skyrocketed and, simultaneously, the patent landscape has become more saturated and complex than ever before. This, coupled with changing legislation, rising R&D costs and increasing regulatory pressures can make the process of managing, protecting and enforcing IP within the life sciences space very challenging.

On May 8th 2025, join 60+ senior IP leaders from across the pharma and biotech arenas to discuss how to ensure an adaptable and future-proof IP strategy.

What to expect:

“The format worked very well - this is easily the conference that I have gotten the most out of in years (also counting countless "in-person" meetings). The roundtable discussions worked extremely well and the topics were very relevant to me and I got a lot of inspiration for my work.” - VP Intellectual Property, Fortune 50 Company

“The round tables were informative and illuminating – I learned a lot and have made some good connections that will be mutually beneficial. Thanks for a great event!” - VP, Global Head Pharma Patents and Policy, Fortune 500 Company

“I thoroughly enjoyed the roundtables, and I found it great to interact with colleagues from other companies. I learned a lot and it was great fun!” - Senior IP Counsel, Biotech Company

Previous
Previous
February 12

IP Collective - Trademark & Brand Protection Europe

Next
Next
June 12

IP Collective - Patents North America